240 related articles for article (PubMed ID: 16354706)
1. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion.
Cheng C; Sharp PA
Mol Cell Biol; 2006 Jan; 26(1):362-70. PubMed ID: 16354706
[TBL] [Abstract][Full Text] [Related]
2. Signal-dependent regulation of splicing via phosphorylation of Sam68.
Matter N; Herrlich P; König H
Nature; 2002 Dec; 420(6916):691-5. PubMed ID: 12478298
[TBL] [Abstract][Full Text] [Related]
3. In vitro FRAP reveals the ATP-dependent nuclear mobilization of the exon junction complex protein SRm160.
Wagner S; Chiosea S; Ivshina M; Nickerson JA
J Cell Biol; 2004 Mar; 164(6):843-50. PubMed ID: 15024032
[TBL] [Abstract][Full Text] [Related]
4. Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.
Nakka KK; Chaudhary N; Joshi S; Bhat J; Singh K; Chatterjee S; Malhotra R; De A; Santra MK; Dilworth FJ; Chattopadhyay S
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):E3374-83. PubMed ID: 26080397
[TBL] [Abstract][Full Text] [Related]
5. An evolutionarily conserved role for SRm160 in 3'-end processing that functions independently of exon junction complex formation.
McCracken S; Longman D; Johnstone IL; Cáceres JF; Blencowe BJ
J Biol Chem; 2003 Nov; 278(45):44153-60. PubMed ID: 12944400
[TBL] [Abstract][Full Text] [Related]
6. The spatial targeting and nuclear matrix binding domains of SRm160.
Wagner S; Chiosea S; Nickerson JA
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3269-74. PubMed ID: 12624182
[TBL] [Abstract][Full Text] [Related]
7. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.
Watermann DO; Tang Y; Zur Hausen A; Jäger M; Stamm S; Stickeler E
Cancer Res; 2006 May; 66(9):4774-80. PubMed ID: 16651431
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin.
McCracken S; Longman D; Marcon E; Moens P; Downey M; Nickerson JA; Jessberger R; Wilde A; Caceres JF; Emili A; Blencowe BJ
J Biol Chem; 2005 Dec; 280(51):42227-36. PubMed ID: 16159877
[TBL] [Abstract][Full Text] [Related]
9. The human SWI/SNF subunit Brm is a regulator of alternative splicing.
Batsché E; Yaniv M; Muchardt C
Nat Struct Mol Biol; 2006 Jan; 13(1):22-9. PubMed ID: 16341228
[TBL] [Abstract][Full Text] [Related]
10. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells.
Cappellari M; Bielli P; Paronetto MP; Ciccosanti F; Fimia GM; Saarikettu J; Silvennoinen O; Sette C
Oncogene; 2014 Jul; 33(29):3794-802. PubMed ID: 23995791
[TBL] [Abstract][Full Text] [Related]
12. A positive feedback loop couples Ras activation and CD44 alternative splicing.
Cheng C; Yaffe MB; Sharp PA
Genes Dev; 2006 Jul; 20(13):1715-20. PubMed ID: 16818603
[TBL] [Abstract][Full Text] [Related]
13. The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo.
Thornton JK; Dalgleish C; Venables JP; Sergeant KA; Ehrmann IE; Lu X; Saunders PT; Elliott DJ
Oncogene; 2006 May; 25(22):3104-12. PubMed ID: 16474851
[TBL] [Abstract][Full Text] [Related]
14. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing.
Zeng Y; Wodzenski D; Gao D; Shiraishi T; Terada N; Li Y; Vander Griend DJ; Luo J; Kong C; Getzenberg RH; Kulkarni P
Cancer Res; 2013 Jul; 73(13):4123-33. PubMed ID: 23667174
[TBL] [Abstract][Full Text] [Related]
15. The SRm160/300 splicing coactivator subunits.
Blencowe BJ; Baurén G; Eldridge AG; Issner R; Nickerson JA; Rosonina E; Sharp PA
RNA; 2000 Jan; 6(1):111-20. PubMed ID: 10668804
[TBL] [Abstract][Full Text] [Related]
16. Distinct CD44 splice variants differentially affect collateral artery growth.
Bot PT; Grundmann S; van Royen N; Joosten SP; Schirmer SH; de Kleijn DP; Pals ST; Pasterkamp G; Piek JJ; Hoefer IE
Curr Vasc Pharmacol; 2013 Jan; 11(1):13-20. PubMed ID: 23391418
[TBL] [Abstract][Full Text] [Related]
17. SRm160 splicing coactivator promotes transcript 3'-end cleavage.
McCracken S; Lambermon M; Blencowe BJ
Mol Cell Biol; 2002 Jan; 22(1):148-60. PubMed ID: 11739730
[TBL] [Abstract][Full Text] [Related]
18. HITS-CLIP reveals sex-differential RNA binding and alterative splicing regulation of SRm160 in Drosophila.
Qiu C; Zhang Y; Fan YJ; Pang TL; Su Y; Zhan S; Xu YZ
J Mol Cell Biol; 2019 Feb; 11(2):170-181. PubMed ID: 29750417
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of the PWI motif: a novel nucleic acid-binding domain that facilitates pre-mRNA processing.
Szymczyna BR; Bowman J; McCracken S; Pineda-Lucena A; Lu Y; Cox B; Lambermon M; Graveley BR; Arrowsmith CH; Blencowe BJ
Genes Dev; 2003 Feb; 17(4):461-75. PubMed ID: 12600940
[TBL] [Abstract][Full Text] [Related]
20. Alternative RNA splicing complexes containing the scaffold attachment factor SAFB2.
Sergeant KA; Bourgeois CF; Dalgliesh C; Venables JP; Stevenin J; Elliott DJ
J Cell Sci; 2007 Jan; 120(Pt 2):309-19. PubMed ID: 17200140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
